CoreSite Realty

CoreSite Realty

Yahoo Finance • 22 hours ago

Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers

Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at Cencora (NYSE:COR) and its peers.... Full story

Yahoo Finance • 5 days ago

3 Market-Beating Stocks for Long-Term Investors

3 Market-Beating Stocks for Long-Term Investors Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost alway... Full story

Yahoo Finance • 8 days ago

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Key Points Eli Lilly and dominance in weight loss and diabetes treatments continues to fuel massive revenue growth. Teva Pharmaceutical Industries offers a value-oriented play as it moves past legal hurdles and expands its biosimilar port... Full story

Yahoo Finance • 9 days ago

Citi's picks and pans for H2 '26: REITs, tech, consumer, health

[Citibank headquarters in Canary Wharf, London, UK] VV Shots Citi released its roadmap for the second half of 2026, including a macro-to-micro view of equity sectors. "Our recently revised S&P 500 (SPY [https://seekingalpha.com/symbol/SP... Full story

Yahoo Finance • 10 days ago

Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”

Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday's market rotation. Cramer said that the stock deserves to "trade higher," as he commented: Can I c... Full story

Yahoo Finance • 12 days ago

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the health insurance providers industry,... Full story

Yahoo Finance • 14 days ago

Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase

Cencora (COR) was Smart Insider's stock pick of the week after Chair Mark Durcan bought $1 million i PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 16 days ago

Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cencora (NYSE:COR) has launched a multi-site pilot of its upgraded Nucleus inventory management solution for specialty physician p... Full story

Yahoo Finance • 18 days ago

3 Big Reasons to Love Cencora (COR)

3 Big Reasons to Love Cencora (COR) Over the past six months, Cencora's stock price fell to $287.06. Shareholders have lost 15.8% of their capital, which is disappointing considering the S&P 500 has climbed by 6.2%. This was partly due to... Full story

Yahoo Finance • 19 days ago

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?

Key Points AbbVie is aggressively expanding its pipeline to offset the impact of biosimilar competition for its top-selling drugs. Pfizer is utilizing substantial capital for acquisitions to diversify its revenue stream and combat upcomin... Full story

Yahoo Finance • 25 days ago

Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?

Key Points Amgen delivers robust cash flow and high net margins through its established portfolio of blockbuster medications. NovoCure offers a unique direct-to-patient model for tumor treatment, targeting niche oncology markets with tumo... Full story

Yahoo Finance • 29 days ago

Cencora Announces Samantha Hammock as Chief Human Resources Officer

Silvana Battaglia to retire after distinguished 7-year tenure CONSHOHOCKEN, Pa., June 15, 2026--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer... Full story

Yahoo Finance • last month

Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price Potential

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Cencora (NYSE:COR) has entered a major U.S. distribution partnership with Kite Pharma, a Gilead company. The agreement focu... Full story

Yahoo Finance • 2 months ago

Cencora Names Eva Boratto EVP, CFO; Reaffirms FY26 Adj. EPS Range

(RTTNews) - Global pharmaceutical solutions provider Cencora, Inc. (COR) Wednesday announced the appointment of Eva Boratto as executive vice president and chief financial officer, effective June 29, 2026. Boratto will succeed James Clea... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. (“Cencora” or the “Company”) (NYSE: COR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw... Full story

Yahoo Finance • 2 months ago

Cencora raises earnings outlook on share repurchases

[Stock Buybacks theme with US shipping port] Melpomenem * Shares of medical distributor Cencora (COR [https://seekingalpha.com/symbol/COR]) spiked in the premarket on Friday after the company raised the midpoint of its earnings outlook... Full story

Yahoo Finance • 2 months ago

Cencora Raises FY26 Outlook; Plans Up To $2 Bln Addl. Share Repurchase

(RTTNews) - Cencora Inc. (COR), a pharmaceutical company, announced that it has raised the lower end of its fiscal 2026 adjusted earnings outlook. Further, the company said its Board of Directors, on May 20th, authorized additional up to $... Full story

Yahoo Finance • 2 months ago

Cencora Announces Updated Fiscal Year 2026 Financial Outlook

The Board of Directors authorized a new $2.0 billion share repurchase program CONSHOHOCKEN, Pa., May 21, 2026--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today updated its fiscal year 2026 financial guidance as a result of recent opportun... Full story

Yahoo Finance • 2 months ago

COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cencora, Inc. (“Cencora” or “the Company”) (NYSE: COR)... Full story

Yahoo Finance • 2 months ago

Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating

Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The letter emphasizes a long-term, fundamentals-driven investment philosophy, arg... Full story